Elisabetta Dejana
Milan, 20139, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
BMI1 Inhibition Improves Lesion Burden in Cerebral Cavernous Malformations.
Journal: Circulation
Published: August 26, 2024
Expression of Concern: Expression of junctional adhesion molecule-A prevents spontaneous and random motility.
Journal: Journal of cell science
Published: January 30, 2024
Circulating biomarkers in familial cerebral cavernous malformation.
Journal: EBioMedicine
Published: August 02, 2023
GPR126 is a specifier of blood-brain barrier formation in the mouse central nervous system.
Journal: The Journal of clinical investigation
Published: September 13, 2022
Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial.
Journal: The Lancet. Neurology
Published: July 29, 2022
Histological quantification of cerebral cavernous malformations in the murine brain.
Journal: STAR protocols
Published: June 17, 2022
Correction: Inflammation and neutrophil extracellular traps in cerebral cavernous malformation.
Journal: Cellular and molecular life sciences : CMLS
Published: May 30, 2022
Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation.
Journal: Blood
Published: March 04, 2022
Inflammation and neutrophil extracellular traps in cerebral cavernous malformation.
Journal: Cellular and molecular life sciences : CMLS
Published: November 25, 2021
Last Updated: 09/26/2026